Company Description

A privately held Swiss biopharmaceutical company.

Redvax is a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. Redvax is a preclinical stage company. The company develops multi-component virus-like particles (VLPs) and other protein assemblies for vaccine development in the field of CMV and a further undisclosed field.

  • Manufacturer:

    Science and Engineering
  • Company Website:

  • Company E-mail:

  • Company Address:

    Wagistrasse 23
    Schlieren
    Switzerland
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits